Every medicine, vaccine, and medical device that reaches a pharmacy shelf or a clinic room has traveled through a long, carefully structured research process. Clinical trials are the formal studies that determine whether a treatment is safe, whether it works, and how it compares to what already exists. Understanding the phases can help future participants feel far more grounded about what to expect.
Before humans are involved
Long before a single volunteer is enrolled, researchers spend years in the laboratory studying how a compound behaves in cells and animal models. This preclinical work establishes a preliminary safety profile and helps investigators estimate reasonable starting doses. Only after regulators review this evidence — in the United States, the Food and Drug Administration — can a treatment be tested in people.
Phase 1: safety and tolerability
Phase 1 trials are typically small, often enrolling a few dozen volunteers. The primary question is not whether the treatment works, but whether it is safe at various dose levels and how the body processes it. Participants are closely monitored, and dosing is escalated gradually. Many Phase 1 studies enroll healthy volunteers, though some — particularly in oncology — enroll people already living with the condition.
Phase 2: does it work in principle?
If Phase 1 supports a safe dosing range, Phase 2 tests the treatment in a larger group of people who have the condition it is designed to help. The focus expands to preliminary evidence of benefit, additional safety data, and side-effect patterns. Studies here often compare the investigational treatment against a placebo or an existing therapy.
Phase 3: confirming benefit at scale
Phase 3 is the pivotal stage. It typically involves hundreds or thousands of participants across many clinical sites, sometimes in multiple countries. The goal is to confirm effectiveness, monitor side effects in a much larger population, and generate the evidence regulators need to consider approval. Phase 3 studies are usually randomized and blinded to protect against bias.
Phase 4: what happens after approval
Once a treatment is approved and available, Phase 4 studies continue to track its long-term safety and real-world performance. This ongoing surveillance sometimes reveals rare side effects that only emerge when a medicine is used by very large populations over many years.
What participants experience day to day
- A detailed screening visit to confirm eligibility and review the informed consent document.
- Scheduled study visits — some routine check-ins, some longer assessments.
- Access to a dedicated research team who can answer questions between visits.
- The freedom to withdraw at any point, for any reason, without penalty.
Every phase, every visit, and every safety check exists because of one goal: making sure treatments are as safe and effective as possible for the people who will eventually use them.
